Clinical Trials Logo

Depression, Unipolar clinical trials

View clinical trials related to Depression, Unipolar.

Filter by:

NCT ID: NCT02954731 Completed - Panic Disorder Clinical Trials

Trans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic Disorder

TRACT-RCT
Start date: December 2016
Phase: N/A
Study type: Interventional

Transdiagnostic Cognitive Behavior Therapy (CBT) delivered in the individual format, have been proven just as effective as traditional diagnosis specific CBT manuals. The investigators have translated and modified the "The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders" (UP-CBT) to make it applicable as group therapy in Danish Mental Health Service and a naturalistic trial of this manual has shown promising results. As the use of one manual instead of several diagnosis specific manuals in regional clinics could simplify logistics and reduce waiting time, the investigators want to compare group UP-CBT with diagnosis specific group CBT. Method: A partial blinded, pragmatic, non-inferiority, multicentre randomized clinical trial (RCT). UP-CBT is compared to treatment-as-usual CT. 124 patients are included in each intervention arm, recruited from three Danish regional Mental Health Service Clinics. 31st July 2018 suppl: Inclusion number expanded to 170 in each arm due to unexpected large drop-out.

NCT ID: NCT02945735 Completed - Depressive Disorder Clinical Trials

Gaze Contingent Feedback in Major Depressive Disorder (MDD)

Start date: November 6, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether giving gaze-contingent feedback is an effective attention modification procedure, helping in the treatment of Major Depressive Disorder (MDD)

NCT ID: NCT02874833 Completed - Bipolar Disorder Clinical Trials

Exercise for Depression

EXDEP
Start date: July 2016
Phase: N/A
Study type: Interventional

A randomized single-blinded prospective study to evaluate the efficacy of an individualized supervised 8-week exercise program in subjects with moderate to severe depressive episodes compared to treatment-as-usual

NCT ID: NCT01874951 Completed - Clinical trials for Major Depressive Disorder

Low-Dose Naltrexone for Depression Relapse and Recurrence

Start date: June 2013
Phase: Phase 2
Study type: Interventional

The purpose of this pilot study is to determine if taking a low dose of naltrexone in addition to an antidepressant medication can help treat relapse or recurrence in people with Major Depressive Disorder (MDD). The U.S. Food and Drug Administration (FDA) has approved naltrexone for the treatment of alcohol dependence and opioid dependence, but the FDA has not approved naltrexone to treat depression. The investigators hypothesize that patients with breakthrough depression on an antidepressant regimen containing a pro-dopaminergic agent assigned to treatment with low dose naltrexone will demonstrate higher rates of response compared to those patients taking placebo.